OMAHA, NE, University Medical Devices (UMD) today announced the closure of its first round of seed funding.
UMD - which brings to market cutting-edge healthcare technology from the University of Nebraska Medical Center and its commercialization wings UNeMed/UNeTech - raised $1.6 million to drive the company's mission of revolutionizing healthcare diagnostics.
The funding round, which began in March 2023 and closed in December, was led by Bright Minds Capital Partners, Invest Nebraska and leaders from AV Legacy Holdings LLC and UMD. This achievement marks a milestone for UMD, propelling the company forward to pursue more innovative healthcare solutions.
University Medical Devices is the medical device developer behind MicroWash. Its mission is to provide cutting-edge and highly reliable specimen collection systems that improve the patient experience. The company's leadership includes experts in neurology, emergency medicine, telehealth, urgent care, primary care, healthcare startup entrepreneurship and healthcare regulation with training at leading medical institutions across the U.S. They also have specialized expertise in biocontainment and pandemic medicine with the National Quarantine Unit - the only federally supported program of its kind - and were among the first to oversee isolation care and serial testing for COVID-19 patients returning to the U.S. at the beginning of the pandemic. NMotion powered by gener8tor, Nebraska's premier startup accelerator, played a key role in UMD's early development.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.